RLLVF:OTC-Relevium Technologies Inc (USD)

COMMON STOCK | Pharmaceutical Retailers |

Last Closing

USD 0.006

Change

0.00 (0.00)%

Market Cap

USD 5.28M

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-31 )

Largest Industry Peers for Pharmaceutical Retailers

Symbol Name Price(Change) Market Cap
JDHIY JD Health International Inc

N/A

USD 16.82B
ALBHF Alibaba Health Information Tec..

N/A

USD 10.86B
JDHIF JD Health International Inc

N/A

USD 10.33B
CLCGY Clicks Group Ltd

-0.49 (-1.13%)

USD 5.14B
RADLY Raia Drogasil SA ADR

+0.08 (+2.75%)

USD 4.65B
SHPPF Shop Apotheke Europe N.V

N/A

USD 2.98B
SAEYY Shop Apotheke Europe N.V

N/A

USD 2.96B
NOTR Nowtransit Inc

N/A

USD 0.57B
ZRSEF Zur Rose Group AG

N/A

USD 0.30B
BLMH Blum Holdings Inc

-0.05 (-7.12%)

USD 0.01B

ETFs Containing RLLVF

VXC:CA Vanguard FTSE Global All .. 26.45 % 0.27 %

+0.27 (+-0.28%)

CAD 2.27B
VBAL:CA Vanguard Balanced Portfol.. 0.00 % 0.25 %

+0.08 (+-0.28%)

CAD 3.43B
VCNS:CA Vanguard Conservative ETF.. 0.00 % 0.25 %

+0.03 (+-0.28%)

CAD 0.54B
VGRO:CA Vanguard Growth Portfolio 0.00 % 0.25 %

+0.17 (+-0.28%)

CAD 6.59B
VCIP:CA Vanguard Conservative Inc.. 0.00 % 0.25 %

N/A

CAD 0.23B
VEQT:CA Vanguard All-Equity ETF P.. 0.00 % 0.25 %

+0.28 (+-0.28%)

CAD 6.50B
VI:CA Vanguard FTSE Developed A.. 0.00 % 0.23 %

+0.15 (+-0.28%)

N/A
VRIF:CA Vanguard Retirement Incom.. 0.00 % 0.00 %

-0.07 (-0.28%)

CAD 0.27B

Market Performance

  Market Performance vs. Industry/Classification (Pharmaceutical Retailers) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain 5,900.00% 100% F 99% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 5,900.00% 100% F 99% N/A
Trailing 5 Years  
Capital Gain -78.57% 67% D+ 25% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -78.57% 67% D+ 25% F
Average Annual (5 Year Horizon)  
Capital Gain 444.38% 92% A 93% A
Dividend Return 444.38% 92% A 93% A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 1,652.51% 12% F 7% C-
Risk Adjusted Return 26.89% 80% B- 68% D+
Market Capitalization 5.28M 50% F 33% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.